SIGN UP FOR A

FREE CONSULTATION

NEXTBACK

Copyright © 2022, Pond Lehocky Giordano, LLP | All Rights Reserved | Privacy Policy | Terms of Use

What is Roundup?

Legal representation information for anyone who has been exposed to Roundup Weed Killer and was subsequently diagnosed with non-Hodgkin's Lymphoma.


Pond Lehocky Giordano is investigating claims against Roundup manufacturer Monsanto on behalf of consumers who were exposed to Roundup and later diagnosed with non-Hodgkin's Lymphoma. For more information, please fill out the contact form. 

Call Us for a Free Case Evaluation: 215-607-2886

Monsanto's Roundup Weed Killer is the most commonly used herbicide in the world, with hundreds of millions of pounds of the chemical used every year in both professional and private settings.

What is the Roundup lawsuit?

The Roundup lawsuit came about as a result of injuries from exposure to the weed killer's active ingredient, glyphosate, which has been found to be a carcinogen that causes non-Hodgkin's Lymphoma as well as various sub-types of the cancer, including:

Mature B-cell lymphomas (about 85% - 90% of NHL cases)

Aggressive:

  • Diffuse large B-cell lymphoma (DLBCL) (31%)
  • Lymphoblastic lymphoma (2%)
  • Primary mediastinal (thymic) large B-cell lymphoma (PMBCL) (2%)
  • High-grade B-cell lymphoma with double or triple hits (HBL)
  • Primary DLBCL of the central nervous system
  • Acquired immunodeficiency syndrome (AIDS)-associated lymphoma
  • Mantle cell lymphoma (MCL) (can present as aggressive or indolent) (6%)
  • Burkitt lymphoma (BL) (2%)
  • Transformed follicular and transformed mucosa-associated lymphoid tissue (MALT) lymphomas
  • Primary cutaneous DLBCL, leg type
  • Primary central nervous system (CNS) lymphoma

Indolent:

  • Follicular lymphoma (FL) (22%)
  • Chronic lymphocytic leukemia/small-cell lymphocytic lymphoma (CLL/SLL) (6%)
  • Lymphoplasmacytic lymphoma (1%)
  • Nodal marginal zone lymphoma (NMZL) (1%)
  • Marginal zone lymphoma (MZL) (8%)
  • Gastric mucosa-associated lymphoid tissue (MALT) lymphoma (5%)
  • Waldenstrom macroglobulinemia (WM)
  • Splenic marginal zone lymphoma (SMZL)

Mature T-cell and natural killer (NK)-cell lymphomas (about 10%-15% of NHL cases)

Aggressive:

  • Peripheral T-cell lymphoma (PTCL), not otherwise specified (6%)
  • Lymphoblastic lymphoma (2%)
  • Subcutaneous panniculitis-like T-cell lymphoma (SPTCL)
  • Systemic anaplastic large-cell lymphoma (ALCL) (2%)
  • Hepatosplenic gamma/delta T-cell lymphoma
  • Enteropathy-type intestinal T-cell lymphoma
  • Angioimmunoblastic T-cell lymphoma (AITL)
  • Primary cutaneous anaplastic large-cell lymphoma

Indolent:

  • Cutaneous T-cell lymphoma (CTCL) (4%)
  • Sezary syndrome (SS)
  • Extranodal NK/T-cell lymphoma (ENK/TCL), nasal type
  • Mycosis fungoides (MF)
  • Adult T-cell leukemia/lymphoma

Who is at risk?

The most at-risk groups for exposure are landscapers, farm workers, garden center & nursery employees, and groundskeepers. Affected individuals have also successfully pursued claims due to exposure and usage that occurred at home.

Roundup settlements

Multiple jury verdicts have come back in favor of injured parties in the amounts of $2 billion, $289 million, and $80 million.

What can you do?

If you or a loved one have been exposed to Roundup or its active ingredient glyphosate resulting in a diagnosis of non-Hodgkin's Lymphoma, or any sub-type of cancer associated with exposure, please fill out the contact form on this page for a free case evaluation to see if you may qualify.

Speak with a Roundup lawsuit attorney today.

Disclaimer: This website is designed for general information only. By completing the form above, you are providing information to Pond Lehocky Giordano and may be contacted by them or another third party. This is Attorney Advertising.